State Street’s CervoMed CRVO Stock Holding History

State Street’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.6K	Hold	20,527	–	–	﹤0.01%	4023
2026 Q1	$80.9K	Hold	20,527	–	–	﹤0.01%	4064
2025 Q4	$162K	Buy	20,527 +2,100	+11%	+$16.9K	﹤0.01%	3947
2025 Q3	$149K	Sell	18,427 -500	-3%	-$4.29K	﹤0.01%	3977
2025 Q2	$119K	Sell	18,927 -93,129	-83%	-$794K	﹤0.01%	3946
2025 Q1	$1.03M	Sell	112,056 -4,200	-4%	-$16K	﹤0.01%	3421
2024 Q4	$272K	Buy	116,256 +11,800	+11%	+$115K	﹤0.01%	3778
2024 Q3	$1.53M	Buy	104,456 +22,903	+28%	+$355K	﹤0.01%	3404
2024 Q2	$1.4M	Buy	+81,553	New	+$1.78M	﹤0.01%	3420
2022 Q2	–	Sell	-6,128	Closed	-$115K	–	4947
2022 Q1	$115K	Hold	6,128	–	–	﹤0.01%	4601
2021 Q4	$140K	Hold	6,128	–	–	﹤0.01%	4486
2021 Q3	$234K	Hold	6,128	–	–	﹤0.01%	4296
2021 Q2	$336K	Buy	+6,128	New	+$339K	﹤0.01%	4010

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

State Street's CRVO Position: Q2 2026 in Review

State Street held its CervoMed (CRVO) position steady in Q2 2026 at 20,527 shares worth $63.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.

State Street first reported a position in CRVO in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.53M in Q3 2024. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

State Street held 20,527 shares of CervoMed worth $63.6K as of Q2 2026.
State Street left its CervoMed share count unchanged in Q2 2026.
CervoMed made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4023 holding.
State Street first reported a position in CervoMed in Q2 2021 and has held it in 13 quarters since.
State Street's CervoMed position peaked at $1.53M in Q3 2024.
37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.